Plain-English translation of NCT07504055 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a non-invasive treatment called transcutaneous spinal cord stimulation (scTS) to help people with spinal cord injuries manage blood pressure problems. The treatment uses gentle electrical pulses applied to the skin over the spine—no surgery needed. Researchers believe this stimulation can help restore the body's natural ability to regulate blood pressure, reducing dangerous drops and spikes that often happen after spinal cord injury.
People with spinal cord injuries often struggle with sudden, dangerous changes in blood pressure—it can drop too low or spike too high—because the injury damages the nerves that normally control this system. This trial is testing whether this new treatment could fix that problem and improve quality of life.
You likely qualify if…
You likely don't qualify if…
You would come in 4 to 5 times per week for 16 to 20 weeks, with each session lasting about one hour. During these sessions, trained staff will apply electrodes to your skin over the spine and deliver gentle electrical stimulation while they monitor how your body responds. You'll also have several follow-up visits over the next few months to track how the treatment is working. The study aims to enroll 40 people but needs 15 to complete all the sessions and assessments.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States